Literature DB >> 9494946

Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight.

J R Hughes1, D K Hatsukami.   

Abstract

Smokers were randomly assigned to 0, 7, 14 or 21 mg doses of transdermal nicotine and had their eating and weight followed for 6 weeks. Among the 66 subjects who were abstinent for all 6 weeks, caloric, carbohydrate and fat intake, hunger, and weight increased in those on placebo, but alcohol, caffeine and protein intake did not. Nicotine patch decreased caloric, carbohydrate and fat intake in a dose-related manner, showed a trend for weight and showed no effect for hunger. Neither abstinence from smoking nor nicotine therapy shifted the percent of calories from sweets or carbohydrates. We conclude nicotine replacement reduces post-cessation increases in eating but does not have a specific effect on sweet intake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9494946     DOI: 10.1016/s0899-3289(97)90013-4

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  19 in total

1.  Mortal quintet of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Cumali Gokce; Ramazan Davran; Seckin Akkucuk; Mustafa Ugur; Cem Oruc
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.

Authors:  Mehmet Sofuoglu; James Poling; Maria Mouratidis; Thomas Kosten
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

3.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

4.  Sickle cell diseases and ileus.

Authors:  Mehmet Rami Helvaci; Akin Aydogan; Seckin Akkucuk; Cem Oruc; Mustafa Ugur
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.

Authors:  Aryeh I Herman; Andrew J Waters; Sherry A McKee; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

6.  α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.

Authors:  Yann S Mineur; Emily B Einstein; Patricia A Seymour; Jotham W Coe; Brian T O'neill; Hans Rollema; Marina R Picciotto
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

7.  High-fat diet meal patterns during and after continuous nicotine treatment in male rats.

Authors:  Ian A Mendez; Luis Carcoba; Paul J Wellman; Antonio Cepeda-Benito
Journal:  Exp Clin Psychopharmacol       Date:  2016-09-19       Impact factor: 3.157

8.  Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine.

Authors:  Mehmet Sofuoglu; Aryeh I Herman; Haleh Nadim; Peter Jatlow
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

9.  Trial Protocol: randomised controlled trial of the effects of very low calorie diet, modest dietary restriction, and sequential behavioural programme on hunger, urges to smoke, abstinence and weight gain in overweight smokers stopping smoking.

Authors:  Deborah Lycett; Peter Hajek; Paul Aveyard
Journal:  Trials       Date:  2010-10-07       Impact factor: 2.279

10.  Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Authors:  Mehmet Sofuoglu; Aryeh I Herman; Marc Mooney; Andrew J Waters
Journal:  Psychopharmacology (Berl)       Date:  2009-08-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.